KIMBERLY PEEK: Open Payments
NPI 1780036137 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,365 in 62 payments from 10 companies in 2025. Trend: 2023 $1,554 · 2024 $1,495 · 2025 $1,365
Food & beverage: $1,365
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $276 |
| GlaxoSmithKline, LLC. | 12 | $254 |
| Eisai Inc. | 9 | $244 |
| PFIZER INC. | 11 | $226 |
| Astellas Pharma US Inc | 8 | $138 |
| ABBVIE INC. | 3 | $88 |
| AstraZeneca Pharmaceuticals LP | 4 | $86 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Fennec Pharmaceuticals, Inc. | 1 | $17 |
| Ethicon US, LLC | 1 | $17 |
Products named: Lenvima, LYNPARZA, JEMPERLI, TIVDAK, Veozah, KEYTRUDA, ELAHERE, ZEJULA.
Industry payments across AL — which companies pay providers there.
